The official blog of the Lung Institute.

COPD Patients Are Saying ‘Yes’ to Cellular Therapy at the Lung Institute in Tampa

4 Nov 2016
| Under Press | Posted by | 4 Comments

Tampa, Fla., November 4, 2016 – Chronic obstructive pulmonary disease (COPD) affects 24 million people in the United States, and with standard of care for chronic lung disease remaining unchanged for over a decade, advancements in regenerative medicine have led a number of people with COPD to opt for alternative treatment methods such as cellular therapy. The Lung Institute in Tampa is the leader in treating select pulmonary conditions using cellular therapy, which refers to the use of cells derived from a patient’s  blood. The Lung Institute Tampa recently celebrated treating 3,000 patients since opening three years ago.

Kathleen B. of Amherst, OH, recently received cellular therapy for COPD from the Lung Institute in Tampa. Unable to enjoy the simple pleasures of life, Kathleen decided with her husband to try cellular therapy from the Lung Institute.

“We quit going out to eat because I would come out, and I would be exhausted,” she said. “I would get out into the foyer of the restaurant and I would be gasping, so we quit going out to dinner, and we quit doing a lot of things because I just couldn’t do them anymore. And I think most people can relate who have breathing problems.”

Kathleen and her husband understood the treatment might not be successful, but decided it was their best option.

“Everybody’s skeptical. I was skeptical,” her husband said. “At the onset, we were anxiously awaiting to see some improvement. And as time passed, we did see some improvement. And it got to the point where, in Kathleen’s words, ‘I almost feel normal.’”

November is National COPD Awareness Month, created to raise awareness about a disease with staggering death rates that receives surprisingly little attention. People die from COPD every day, but because COPD is seen as a self-inflicted result of smoking, people tend to be less sympathetic. Many people don’t realize that not everyone with COPD is a current or ex-smoker. According to an article on Everyday Health, about 20 percent of people with COPD never smoked.

When faced with a deadly illness like COPD, a strong support group is imperative. “It almost takes a team to get through this type of illness,” said Kathleen’s husband. “If you’ve got a good team, then you’re okay.”

“And we have a good team,” Kathleen said.

About the Lung Institute 

The Lung Institute is the leading medical provider of regenerative cellular therapy for lung diseases such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis and interstitial lung disease in the United States. To date the organization has treated over 3,000 patients. The Lung Institute’s in-house outcomes summary shows that 84.5 percent of COPD patients studied saw an improvement in their quality of life. In 2013, the Lung Institute in Tampa, Fla. opened. Now, the Lung Institute operates clinics in Tampa, Fla., Nashville, Tenn., Scottsdale, Ariz., and Pittsburgh, Pa. and Dallas, Texas. For more information, please visit www.lunginstitute.com or call (800) 382-8095.

*For more information, go to www.LungInstitute.com/Results.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.